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Abstract
The COVID-19 pandemic is evolving fast and affecting rich and poor countries; however, the
social determinants of the health outcomes associated with COVID-19 have not been well
characterized. While there is increasing discussion of COVID-19 disparities in the media, no
systematic compilation of data exists that synthesizes what and how official reporting platforms
disaggregate demographic indicators of COVID-19 testing, cases, hospitalizations, recoveries
and deaths. This review will provide a comprehensive overview of what and how federal and
local health officials report COVID-19 cases. Having this information nationally and subnationally can help health officials to deploy a more targeted response effort such as testing,
treatment, and contact tracing. This information could be useful for future vaccine
development. This data review can reveal gaps in our public health data system, which can lead
to recommendations on how to improve data standardization, disaggregation, and reporting,
particularly for tracking outbreaks. This protocol may be replicated in other countries to
understand how demographic indicators are being reported and their relationship to COVID-19
health outcomes.
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This document is evolving due to the nature of the COVID-19 response and will be updated as needed.

Background
The World Health Organization (WHO) Commission on Social Determinants of Health asserts
that political, social, and economic forces shape the circumstances in which people live. These
circumstances give rise to avoidable health inequities, both within and between countries, which
are strongly linked to degrees of social disadvantage1. In an article from the Annual Review of
Public Health, Adler and Rehkopf describe that “physical and social environments, including a
person’s home, school, work, neighborhood, and community, vary by socio-economic status
(SES) and affect the likelihood of individuals’ exposure to both health-damaging conditions and
health-protecting resources”2. Factors including race/ethnicity, gender, income, occupation,
education level, and geographic location all have an impact on health outcomes, such as
morbidity and mortality rates. The first study in the United States (US) to examine
socioeconomic disparities within race/ethnicity using individual-level data from the 1960
matched records of people 25 years of age and older. This study found that compared to whites,
age-adjusted, all-cause mortality rates were 34% higher for nonwhite females and 20% higher
for males. The same study found that males and females who are the least educated
experience 64% and 105% higher mortality rates, respectively, compared to those most
educated2. Similar trends are apparent in maternal mortality rates. Recent data from the Center
for Disease Control and Prevention (CDC) shows that non-Hispanic black women have a rate of
37.1 deaths per 100,000 live births, compared to non-Hispanic white women who have a rate of
14.7 deaths per 100,000 live births3. Despite the recognition that addressing these disparities is
critical to tackling health inequity and protecting public health, data systems, research and
policies that directly tackle these key social determinants continue to lag behind in the US and
globally.
During the ongoing COVID-19 pandemic, the data on COVID-19 confirmed cases and deaths in
the US are increasingly revealing that people of color are more severely affected by the novel
coronavirus. On April 7, the surgeon general first acknowledged the racial disparities of COVID19 based on case reports from a few states, including Louisiana, Michigan, and Illinois4.
Analysis of these reports suggested that majority-black counties had three times the infection
rate and six times the death rate as majority-white counties4. As more states began to release
socio-demographic data related to COVID-19, similar trends appeared. In New York, black
people make up nine percent of the population but account for 17 percent of the deaths5. In
addition to the racial disparities, COVID-19 is affecting poor people more severely and is
infecting and killing more men than women, is killing older populations compared to young age
groups, and is infecting urban populations more than rural ones6, 7. On April 17 2020, the CDC
released the first report on COVID-19 containing socio-demographic data collected from only 14
states during the month of March. The report stated that only 18% of residents in the sample
population were black, yet blacks made up 33% of those hospitalized with COVID-19. In
comparison, while 59% of residents in the sample population were white, they made up just
45% of those hospitalized with COVID-198. Public health and medical experts are stressing the
fact that people of color, in general, are not more susceptible to the virus, but they are more
susceptible to experiencing more severe illness and worse health outcomes as a result of the
virus due to the existing health inequities in the US9.
Historically, epidemics disproportionately affect vulnerable communities, including those living in
poor and crowded neighborhoods, women and girls, gender minority individuals, and people

living in poverty. In the article Health Inequities and Infectious Disease Epidemics, Quinn and
Kumar describe, “poverty, inequality, and social determinants of health create conditions for the
transmission of infectious diseases, and existing health disparities or inequalities can further
contribute to unequal burdens of morbidity and mortality”10. During a pandemic, these inequities
become more visible due to the greater impact on vulnerable populations. During the H1N1
pandemic, Quinn and Kumar found that those who were at the highest risk of exposure to H1N1
were those of lower socioeconomic status and were likely to have less access to care if they
contracted the disease11. Similarly, Dr. Anthony Fauci compared COVID-19 to the HIV
pandemic, where HIV affected the gay communities at higher rates compared to the general
population, and the COVID-19 pandemic is bringing attention to the racial disparities on health
in the US9. 2018 data from the CDC continues to show that Black/African American gay,
bisexual, and other men were more affected by HIV than any other group in the US12.
Understanding the socio-demographic trends of COVID-19 could help with deploying preventive
and mitigation measures as well as treatment and relief. Having information on who is most
affected by this pandemic will help state level governments and local officials to plan a response
and offer more support to communities and individuals who need it the most. Further, extensive
research has demonstrated that factors including sex, pregnancy, and comorbid conditions can
impact the immune response to vaccines13. Therefore, understanding socio-demographic
factors of those most affected by COVID-19 is critical in the development of an effective
vaccine. More generally, Dr. Lisa A. Cooper, Professor at the Johns Hopkins Bloomberg School
of Public Health and Johns Hopkins School of Medicine, explains that “health and public health
professionals, administrators, employers, policymakers, and even community advocates can
use these data to determine how best to use the vast resources we have in this country to
improve the lives of our people”14.
Prevention, mitigation, treatment and relief efforts cannot occur without adequate data and
reporting of socio-demographic factors of COVID-19 cases. As a result of the early data
suggesting extreme racial disparities in the COVID-19 pandemic, the federal government is
being pressured to not only release racial data on cases and deaths, but also release a plan to
“blunt the devastation” on people and communities of color15. Although, the WHO does not
produce official analyses and routine reporting on the socio-demographic factors related to
COVID-19 confirmed cases, hospitalizations, deaths and recoveries. The CDC only began
reporting this information in 28% of states on April 17, almost three months after the first
reported case in the US. In the US, data revealing racial disparities of COVID-19 come from
state governments reports; however, these reports are not standardized between states, and
the available information is not systematically synthesized at the national level. Together, this
highlights the failure of the US public health data system to capture and analyze this information
in order to contribute to the test, treat, trace, and isolate initiative, which is needed to reduce
and suppress the spread of coronavirus. Capturing and analyzing this information is critical in
recording and tackling health inequity in the United States.
Objectives
We are conducting a data review of COVID-19 to examine how cases are reported in the US
and how this reporting has changed over time with the following objectives:

1. To assess whether official or reliable case reports of COVID-19 are disaggregated by
key demographic indicators, age, sex, race/ethnicity, education level, geography,
economic status, and underlying conditions.
2. To assess how COVID-19 affects different population groups by cases, testing,
hospitalizations, recoveries and deaths.
3. To describe how the patterns of case reports of COVID-19 change over time and from
earlier epicenters to recent epicenters since the first confirmed case.
Methods
This data review examined COVID-19 reports in the US using 70 data sources from the Centers
for Disease Control and Prevention (CDC) and health departments across 50 states, US
territories, and ten major cities. The data review protocol is published on Dataverse15.
Data Sources Included
We included data from 70 sources in our review (the CDC, and health departments of 50 states,
10 cities, and 9 jurisdictions). We used data from each source’s health department website
because we were specifically looking for how national, state, and local health departments
report on COVID-19. For each source, information was extracted from three different types of
data reports: primary, secondary, and tertiary data. Primary reports are daily or weekly situation
reports released by local, state, and the national government. Secondary reports are reports
available on each health department’s COVID-19-specific website or COVID-19 dashboard.
Tertiary reports are reports presented by a third-party entity linked to each health department’s
website.
We did not include reports from news articles, published papers (e.g., papers synthesizing and
analyzing governments reports, or information from tracking sites that compile government data
(e.g., Johns Hopkins University Coronavirus Resource Center COVID-19 Case Tracker). We
excluded reports from county health departments.
Search Strategy
The CDC webpage reporting COVID-19 cases in the US provides links to each US jurisdiction’s
health department, from which the CDC retrieves its national data16. Using this resource, we
accessed each jurisdiction’s health department webpage to determine what and how each
health department reported on COVID-19. The US jurisdictions identified through the CDC
include 50 states and 9 territories. The territories are American Samoa, Guam, Marshall Islands,
Micronesia, Northern Marianas, Palau, Puerto Rico, Virgin Islands, and the District of Columbia.
We also used the Johns Hopkins University Coronavirus Resource Center website to identify
the ten major cities with the highest number of confirmed COVID-19 cases (between May 30,
2020)1. The ten cities identified were New York City, Los Angeles, Philadelphia, Miami, New
Orleans, Chicago, Detroit, Seattle, Boston, and Houston. We then searched Google for each
city’s health department webpage to determine what and how each city health department
reported on COVID-19.

In this review, ‘sources’ refer to the health department webpage for the CDC, 50 states, 9
territories, and 10 cities, for a total of 70 sources. For each source, we looked reporting on five
key outcomes on interest and disaggregation of these outcomes by seven key demographic
indicators, for a total of 40 indicators and outcomes. We also examined which sources included
intersectional analysis in their reports by looking for disaggregation of outcomes by the
intersection of more than one indicator (i.e. cases disaggregated by age, broken down by sex.
We recorded which sources included any intersectional analysis for at least one outcome. To
review each source, we first looked for a published daily or weekly COVID-19 report. We then
looked for information presented separately from an official report, including information on the
health department’s webpage and/or dashboard designated to COVID-19. Finally, we looked at
whether the health department provided links to external sources with additional data on
COVID-19 for that city, state, or territory.
We began the review of the sources on May 14, 2020 and completed the review on May 30,
2020. One researcher recorded how many and which of the 40 outcomes and indicators each
source reported, and if each source reported intersectionality. Another researcher verified this
information. Any disagreements were discussed among all three researchers.
Outcomes of interest
We extracted data on four COVID-19 outcomes (cases, hospitalizations, recoveries, and
deaths) and testing. We refer to these as the five key outcomes.
Testing refers to the total amount of positive and negative test results from state, commercial,
and clinical laboratory tests. Tests include Polymerase Chain Reaction (PCR) and serology
tests for SARS-CoV-2. Because someone can get tested more than once, the number of tests
does not refer to the number of people who have been tested.
Cases refer to confirmed and probable COVID-19 cases. According to the CDC, a confirmed
case is defined by meeting confirmatory laboratory evidence for COVID-19. A probable case is
defined by i) meeting clinical criteria AND epidemiologic evidence with no confirmatory
laboratory testing performed for COVID-19; or ii) meeting presumptive laboratory evidence AND
either clinical criteria OR epidemiologic evidence; or iii) meeting vital records criteria with no
confirmatory laboratory testing performed for COVID1916.
Hospitalizations refer to reported hospital beds and/or intensive care units (ICU) occupied by
confirmed or probable COVID-19 cases.
Recoveries refer to those who have presumably recovered from a confirmed COVID-19
diagnosis. The definition of recoveries varies between sources. The different definitions of
recoveries are described in Table 1.
Deaths refer to the confirmed and probable deaths due to COVID-19. Based on the CDC
definition, a confirmed death is a death caused by COVID-19 as confirmed by laboratory
evidence. A probable death is defined by i) meeting clinical criteria AND epidemiologic evidence
with no confirmatory laboratory testing performed for COVID-19; or ii) meeting presumptive
laboratory evidence AND either clinical criteria OR epidemiologic evidence; or iii) meeting vital
records criteria with no confirmatory laboratory testing performed for COVID1916.

Demographic indicators and underlying conditions
We consider demographic indicators as age, sex, race/ethnicity, education level, geography,
economic status, and underlying conditions. In this data review, we examine the disaggregation
of these indicators by the five outcomes. Geography is defined as the county (or zip code for
cities) in which the case was reported. This information allows for understanding the distribution
of the outcomes in different poor versus less-poor counties.
The CDC reports the most common underlying conditions among COVID-19 cases in the US as
cardiovascular disease, diabetes, and chronic lung disease17. The CDC also reports the
following as underlying conditions: asthma, autoimmune disease, gastrointestinal/liver disease,
hypertension, immune suppression, metabolic disease, neurologic disease, obesity, pregnancy,
renal disease, and other diseases18.
Analysis
We created an Excel database to record whether each source reports on the five outcomes and
the seven demographic indicators for each outcome. Each source is given an ‘overall
completeness score”, ranging from 0 to 40, representing how many of the 40 indicators and
outcomes each source reported. A total score of 40 would indicate that the source is “complete”,
with “complete” defined as: all indicators and outcomes are incorporated into the data report.
We also assessed how many of the 7 indicators were reported to generate a score representing
the completeness of each outcome. For each data source, each outcome is given an “outcome
completeness score” ranging from 0 to 7, representing how many of the 7 indicators are
reported for each outcome.
For each data source, we also assessed whether the demographic indicators were cross
tabulated by outcomes (i.e. cases by sex broken down by age), which is how we assessed
intersectionality. We considered a source to report on intersectionality if they cross-tabulated at
least two indicators by at least one outcome. We also recorded what indicators were cross
tabulated by what outcomes for each source.
We also conducted a sub-analysis, which excluded education level, economic status, and
underlying conditions as indicators, resulting in a total of 25 indicators and outcomes instead of
40 indicators and outcomes. In this sub-analysis, the “overall completeness score” ranged from
0 to 25 instead of 0 to 40, and the “outcome completeness score” ranged from 0 to 4 instead of
0 to 7.
Implications of our review
This review will provide a comprehensive overview of what and how federal and local health
officials report COVID-19 cases. Having this information nationally and sub-nationally can help
health officials to deploy a more targeted response effort and can help reveal information that
could be useful for testing, treatment, and vaccine development efforts. Further, this data
review may reveal gaps in our public health data system in which we can make
recommendations on how to improve data standardization, disaggregation, and reporting,

particularly for tracking outbreaks. This protocol may be replicated to other countries to
understand how demographic indicators are being reported and their relationship to COVID-19
cases.
Proposed Tables:
1. Description of data sources included in the review
2. Description of overall completeness of reporting by national, state, city, and territory
health departments
3. Description of how national, state, city, and territory health departments report COVID19 outcomes (testing, cases, hospitalizations, recoveries, deaths) are reported by
demographic indicators
4. An analysis of disparities of COVID-19 cases nationally and by states
5. An analysis of how reporting of socio-demographic characteristics changes over the
course of the COVID-19 epidemic

Table 1. Definitions of recoveries by source
Source
Alabama, Alaska,
Arkansas, Delaware,
Hawaii, Iowa, Kentucky,
Maryland, New Hampshire,
New Mexico, Washington,
West Virginia, New York
City, Los Angeles,
Philadelphia, Boston,
Houston
Mississippi, Louisiana

Idaho, Michigan
Ohio
Maine, South Dakota

Minnesota

Montana
North Carolina

North Dakota
Oklahoma
Oregon
South Carolina

Tennessee

Texas
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Definition
Not specified

1) it has been 14 days or more since the case tested positive, if they
were not hospitalized; 2) it has been 21 days or more since the case
tested positive, if they were hospitalized or hospitalization was unknown
Persons with a confirmed COVID-19 diagnosis who are alive 30 days
post-onset (or referral date if onset is not available).
Cases with a symptom onset date >21 days prior who are not deceased
Met the released from isolation requirements defined by CDC. The
requirements are: at least 3 days (72 hours) have passed since
recovery, defined as resolution of fever without the use of fever-reducing
medications and improvement in respiratory symptoms (e.g., cough,
shortness of breath); and, at least 10 days have passed since symptoms
first appeared.
It used “people no longer need self-isolation” as a substitute for
“recovered”. However, it is reported that the definition has changed
many times2.
Persons who have cleared the illness and are released from isolation.
Estimates a median time to recovery of 14 days from the date of
specimen collection for non-fatal COVID-19 cases who were not
hospitalized, or if hospitalization status is unknown. The estimated
median recovery time is 28 days from the date of specimen collection for
hospitalized non-fatal COVID-19 cases.
Cases who tested positive and have since been released from isolation
and are no longer contagious.
Currently not hospitalized or deceased and 14 days after onset/report
People are assumed to have recovered three days after resolution of all
symptoms.
1) Those who reported being hospitalized/where hospitalization status
was unknown: having no reported adverse outcome reported as of >32
days since their illness onset;
2) Those who reported not being hospitalized: having no reported
adverse outcome reported as of >14 days since their illness onset.
1) have been confirmed to be asymptomatic by their local or regional
health department and have completed their required isolation period or
2) are at least 21 days beyond the first test confirming their illness.
“Estimated based on several assumptions related to hospitalization rates
and recovery times, which were informed by data available”.

https://www.startribune.com/coronavirus-covid-19-minnesota-tracker-map-county-data/568712601/

Utah
Vermont

Wisconsin

Wyoming

The number of cases whose first positive laboratory test was reported at
least 21 days ago, excluding deaths.
1) People who have tested positive for COVID-19 report they have
recovered to our investigation teams during their follow-up calls. 2) Thirty
days or more have passed since the date the person's illness began.
the number of confirmed cases who are currently alive based on
Wisconsin state vital records system data and had one or more of the
following:
1) Documentation of resolved symptoms
2) Documentation of release from public health isolation
3) 30 days since symptom onset or diagnosis
1) A lab confirmed or probable case: resolution of fever without the use
of fever-reducing medications and there is improvement in respiratory
symptoms for 72 hours AND at least 10 days have passed since
symptoms first appeared.
2) Cases with laboratory-confirmed COVID-19 who have not had any
symptoms: at least 10 days have passed since the date of their first
positive test and have had no subsequent illness provided they remain
asymptomatic.
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